Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma

被引：45
|
作者：
Mangel, J [1 ]
Buckstein, R [1 ]
Imrie, K [1 ]
Spaner, D [1 ]
Crump, M [1 ]
Tompkins, K [1 ]
Reis, M [1 ]
Perez-Ordonez, B [1 ]
Deodhare, S [1 ]
Romans, R [1 ]
Pennell, N [1 ]
Robinson, JB [1 ]
Hewitt, K [1 ]
Richardson, P [1 ]
Lima, A [1 ]
Pavlin, P [1 ]
Berinstein, NL [1 ]
机构：
[1] Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto Sunnybrook Reg Canc Ctr, Adv Therapeut Program, Toronto, ON M4N 3M5, Canada
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 01期
关键词：
D O I：
10.1053/sonc.2002.30143
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：56 / 69
页数：14
相关论文
共 50 条
  • [41] Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma
    Kasamon, Y. L.
    Jones, R. J.
    Brodsky, R. A.
    Fuchs, E. J.
    Matsui, W.
    Luznik, L.
    Powell, J. D.
    Blackford, A. L.
    Goodrich, A.
    Gocke, C. D.
    Abrams, R. A.
    Ambinder, R. F.
    Flinn, I. W.
    ANNALS OF ONCOLOGY, 2010, 21 (06) : 1203 - 1210
  • [42] High-dose therapy with stem-cell transplantation in the malignant lymphomas
    Winter, JN
    ONCOLOGY-NEW YORK, 1999, 13 (12): : 1635 - 1645
  • [43] Upfront stem cell transplantation with the rituximab/TBI/CY high-dose regimen is an effective treatment for mantle cell lymphoma
    Seyfarth, B
    Sonnen, R
    Pott, C
    Kneba, M
    Schmitz, N
    Dreger, P
    BONE MARROW TRANSPLANTATION, 2002, 29 : S89 - S89
  • [44] Idiotype Immunization Following High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma
    Costello, Caitlin L.
    Holman, Peter
    de Magalhaes-Silverman, Margarida
    Corringham, Sue
    Castro, Januario E.
    Ball, Edward D.
    BLOOD, 2011, 118 (21) : 1724 - 1724
  • [45] Idiotype Immunization Following High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma
    Holman, Peter R.
    Costello, Caitlin
    deMagalhaes-Silverman, Margarida
    Corringham, Sue
    Castro, Januario
    Ball, Edward D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : 257 - 264
  • [46] Favorable influence of pretransplant rituximab but not of high-dose ara-C in upfront autologous stem cell transplantation (SCT) for mantle cell lymphoma (MCL).
    Rieger, M
    Hensel, M
    Seyfarth, B
    Sitter, S
    Martin, S
    Haas, R
    Kneba, M
    Schmitz, N
    Ho, AD
    Dreger, P
    BLOOD, 2005, 106 (11) : 591A - 591A
  • [47] High-dose rituximab in combination with autologous stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma
    Shi, Yi-Fen
    Zhou, Shu-Juan
    Sun, Lan
    Yu, Kang
    Chen, Yi
    MEDICINA CLINICA, 2020, 155 (06): : 235 - 241
  • [48] The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma
    Cakar, Merih K.
    Tekgunduz, Emre
    Dal, Mehmet S.
    Merdin, Alparslan
    Basci, Semih
    Iskender, Dicle
    Ugur, Bilge
    Bekdemir, Filiz
    Yildiz, Jale
    Ulu, Bahar U.
    Bakirtas, Mehmet
    Yigenoglu, Tugce N.
    Batgi, Hikmetullah
    Kaya, Ali H.
    Altuntas, Fevzi
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (02) : 273 - 278
  • [49] High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma
    Park, Kwonoh
    Yoon, Dok Hyun
    Kim, Shin
    Park, Chan-Sik
    Huh, Jooryung
    Lee, Sang-Wook
    Suh, Cheolwon
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (02) : 256 - 262
  • [50] High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma
    Kwonoh Park
    Dok Hyun Yoon
    Shin Kim
    Chan-Sik Park
    Jooryung Huh
    Sang-Wook Lee
    Cheolwon Suh
    International Journal of Hematology, 2013, 97 : 256 - 262
12345